- Hjem
- Amsterdam
- Selskapsmeldinger
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
10 Feb 2023 07:30 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
10 Feb 2023 07:30 CET |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
10 Feb 2023 07:07 CET |
APERAM | Aperam annonce son calendrier de versement de dividendes pour 2023 | 55102010 Iron and Steel | Dividend |
10 Feb 2023 07:07 CET |
APERAM | Aperam announces dividend payment schedule for 2023 | 55102010 Iron and Steel | Dividend |
10 Feb 2023 07:03 CET |
APERAM | Aperam & Econick ont créé une joint-venture Botanickel avec l’ambition de devenir un leader mondial dans la production responsable et durable de nickel biosourcé pour l’industrie de l’acier inoxydable | 55102010 Iron and Steel | Joint venture |
10 Feb 2023 07:03 CET |
APERAM | Aperam & Econick have formed a JV called Botanickel to become a world leader in the responsible and sustainable production of biosourced nickel for the stainless steel industry. | 55102010 Iron and Steel | Joint venture |
10 Feb 2023 06:58 CET |
APERAM | Résultats de l’année 2022 et du quatrième trimestre 2022 | 55102010 Iron and Steel | Commercial results |
10 Feb 2023 06:58 CET |
APERAM | Full year and fourth quarter 2022 results | 55102010 Iron and Steel | Commercial results |
09 Feb 2023 22:01 CET |
GALAPAGOS | Galapagos heeft bemoedigende eerste gegevens gepresenteerd over veiligheid en werkzaamheid van point-of-care vervaardigde CAR-T kandidaat, GLPG5201, in rrCLL, op EBMT-EHA 2023 | 20103010 Biotechnology | Other subject |
09 Feb 2023 22:01 CET |
GALAPAGOS | Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL | 20103010 Biotechnology | Other subject |
09 Feb 2023 18:05 CET |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
09 Feb 2023 10:00 CET |
WOLTERS KLUWER | Share Buyback Transaction Details February 2 – February 8, 2023 | 40301030 Publishing | Share introduction and issues |
09 Feb 2023 07:30 CET |
FLOW TRADERS | FLOW TRADERS Q422 RESULTS | 30202015 Investment Services | Commercial results |
09 Feb 2023 07:30 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
09 Feb 2023 07:30 CET |
UNIBAIL-RODAMCO-WESTFIELD | Unibail-Rodamco-Westfield Reports FY-2022 Earnings | 35102045 Retail REITs | Other subject |
09 Feb 2023 07:30 CET |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
09 Feb 2023 07:00 CET |
WERELDHAVE Gewone aandelen | Wereldhave Full-year results 2022 | 35102045 Retail REITs | Commercial results |
09 Feb 2023 07:00 CET |
AEGON | Aegon reports fourth quarter 2022 results | 30301010 Life Insurance | Commercial results |
09 Feb 2023 07:00 CET |
ARCELORMITTAL SA | ArcelorMittal reports fourth quarter 2022 results | 55102010 Iron and Steel | Other subject |
09 Feb 2023 07:00 CET |
AEGON | Aegon rapporteert resultaten over vierde kwartaal 2022 | 30301010 Life Insurance | Commercial results |
08 Feb 2023 22:45 CET |
PERSHING SQUARE HOLDING | Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 7 February 2023 | 30204000 Closed End Investments | Other subject |
08 Feb 2023 22:01 CET |
GALAPAGOS | Galapagos kondigt topline resultaten aan van fase 3 DIVERSITY-studie met filgotinib bij de ziekte van Crohn | 20103010 Biotechnology | Other subject |
08 Feb 2023 22:01 CET |
GALAPAGOS | Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease | 20103010 Biotechnology | Other subject |
08 Feb 2023 20:30 CET |
BE Semiconductor Industries N.V. | BE Semiconductor Industries N.V. Announces Transactions Under Share Repurchase Program | 10102010 Semiconductors | Other subject |
08 Feb 2023 18:45 CET |
FLOW TRADERS | REPURCHASE OF SHARES | 30202015 Investment Services | Other financial transaction |
08 Feb 2023 18:05 CET |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
08 Feb 2023 17:30 CET |
MAREL | Marel: Ramp up of revenues and improved EBIT of 12.4% | 50204050 Machinery: Specialty | Other subject |
08 Feb 2023 17:30 CET |
MAREL | Góður tekjuvöxtur og 12,4% EBIT framlegð á fjórða ársfjórðungi | 50204050 Machinery: Specialty | Other subject |
08 Feb 2023 17:00 CET |
SHELL PLC | Director/PDMR Shareholding | 60101000 Integrated Oil and Gas | Other subject |
08 Feb 2023 12:12 CET |
SHELL PLC | Director/PDMR Shareholding | 60101000 Integrated Oil and Gas | Other subject |
08 Feb 2023 11:32 CET |
ABN AMRO BANK N.V. | Correction headline typo: ABN AMRO rapporteert EUR 1.867 miljoen winst over 2022 en kondigt inkoop eigen aandelen aan | 30101010 Banks | Commercial results |
08 Feb 2023 11:32 CET |
ABN AMRO BANK N.V. | Correction headline typo: ABN AMRO reports net profit of EUR 1,867 million for FY2022 and announces share buyback | 30101010 Banks | Commercial results |
08 Feb 2023 09:13 CET |
AMUNDI PHYSICAL GOLD ETC | Amundi Physical Metals plc: UK Final Terms | - | Other subject |
08 Feb 2023 09:09 CET |
AMUNDI PHYSICAL GOLD ETC | Amundi Physical Metals plc: Final Terms | - | Other subject |
08 Feb 2023 09:06 CET |
AMUNDI PHYSICAL GOLD ETC | Amundi Physical Metals plc: UK Final Terms | - | Other subject |
08 Feb 2023 08:23 CET |
AMUNDI PHYSICAL GOLD ETC | Amundi Physical Metals plc: Final Terms | - | Other subject |
08 Feb 2023 08:17 CET |
AMUNDI PHYSICAL GOLD ETC | Amundi Physical Metals plc: UK Final Terms | - | Other subject |
08 Feb 2023 08:13 CET |
AMUNDI PHYSICAL GOLD ETC | Amundi Physical Metals plc: Final Terms | - | Other subject |
08 Feb 2023 08:09 CET |
AMUNDI PHYSICAL GOLD ETC | Amundi Physical Metals plc: UK Final Terms | - | Other subject |
08 Feb 2023 08:06 CET |
AMUNDI PHYSICAL GOLD ETC | Amundi Physical Metals plc: Final Terms | - | Other subject |
08 Feb 2023 08:00 CET |
VEON | VEON Announces Russian Regulatory Approval for Sale of Its Operations | 15102015 Telecommunications Services | Other subject |
08 Feb 2023 07:30 CET |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
08 Feb 2023 07:30 CET |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
08 Feb 2023 07:05 CET |
ABN AMRO BANK N.V. | ABN AMRO announces EUR 500 million share buyback programme | 30101010 Banks | Other subject |
08 Feb 2023 07:05 CET |
ABN AMRO BANK N.V. | ABN AMRO maakt aandeleninkoopprogramma van EUR 500 miljoen bekend | 30101010 Banks | Other subject |
08 Feb 2023 07:00 CET |
ABN AMRO BANK N.V. | ABN AMRO reports net profit of EUR 1,876 million for FY2022 and announces share buyback | 30101010 Banks | Commercial results |
08 Feb 2023 07:00 CET |
ABN AMRO BANK N.V. | ABN AMRO rapporteert EUR 1.876 miljoen winst over 2022 en kondigt inkoop eigen aandelen aan | 30101010 Banks | Commercial results |
07 Feb 2023 19:00 CET |
Boussard Gavaudan | Cancellation of Euro Shares Held in Treasury | 30204000 Closed End Investments | Change in Capital |
07 Feb 2023 18:28 CET |
ACOMO N.V. | ACOMO DOCHTERMAATSCHAPPIJ ONTVANGT DAGVAARDING IN RELATIE TOT BEËINDIGING VAN LEVERANCIERSRELATIE EN BETWIST CLAIM | 45102020 Food Products | Legal |
07 Feb 2023 18:28 CET |
ACOMO N.V. | ACOMO SUBSIDIARY HAS BEEN SUMMONED BY SUPPLIER IN RELATION TO TERMINATED BUSINESS RELATIONSHIP AND CONTESTS CLAIM | 45102020 Food Products | Legal |